"There is an opportunity to invest at less than half the fundamental asset value for investors prepared to take on high risk at appropriate weightings."
That was from the Wilson HTM report when the share price was 69 cents. Now it is 43.
Hoping the price will settle now before April 9 when a bit more information on the issue of the diagnostic will be released to the market. ie. strategy and expected duration of the validation testing.
CXS Price at posting:
43.0¢ Sentiment: Buy Disclosure: Held